marketcaparena
Search

    FATE

    FATE THERAPEUTICS INC

    Company overview

    Market capitalization
    $285.17M
    Employees
    161
    Latest publication
    2026-09-29
    About FATE THERAPEUTICS INC

    Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue2,082,000USD1,299,000USD1,369,000USD1,741,000USD1,907,000USD1,629,000USD1,860,000USD3,074,000USD
    Research Development24,387,000USD21,785,000USD25,425,000USD25,838,000USD27,430,000USD29,136,000USD33,609,000USD34,650,000USD
    Selling General Administrative8,829,000USD9,596,000USD10,665,000USD10,638,000USD11,445,000USD13,773,000USD15,262,000USD20,801,000USD
    General And Administrative Expenses8,829,000USD———————
    Total Operating Expenses33,216,000USD31,381,000USD36,090,000USD36,476,000USD38,875,000USD42,909,000USD63,608,000USD55,451,000USD
    Operating Income-31,134,000USD-33,000,000USD-34,721,000USD-34,735,000USD-36,968,000USD-41,280,000USD-61,748,000USD-52,377,000USD
    Total Other Income Expense Net975,000USD1,787,000USD2,347,000USD2,485,000USD2,898,000USD3,659,000USD9,595,000USD4,699,000USD
    Interest Income1,555,000USD1,867,000USD2,220,000USD2,575,000USD2,921,000USD3,336,000USD3,874,000USD4,438,000USD
    Net Income-30,159,000USD-31,213,000USD-32,374,000USD-32,250,000USD-34,070,000USD-37,621,000USD-52,153,000USD-47,678,000USD
    Cost Of Revenue—2,918,000USD3,063,000USD—3,278,000USD—4,813,000USD4,607,000USD
    Gross Profit—-1,619,000USD1,369,000USD1,741,000USD1,907,000USD1,629,000USD1,860,000USD3,074,000USD
    Net Interest Income—1,867,000USD2,220,000USD2,575,000USD2,921,000USD3,336,000USD3,874,000USD4,438,000USD
    Income Before Tax—-31,213,000USD-32,374,000USD-32,250,000USD-34,070,000USD-37,621,000USD-52,153,000USD-47,678,000USD
    Net Income From Continuing Ops—-31,213,000USD-32,374,000USD-32,250,000USD-34,070,000USD-37,621,000USD-52,153,000USD-47,678,000USD
    Ebit—-33,000,000USD-34,721,000USD-32,250,000USD-34,070,000USD-41,280,000USD-47,011,000USD-52,377,000USD
    Ebitda—-30,082,000USD-31,658,000USD-29,023,000USD-30,792,000USD-37,947,000USD-42,198,000USD-47,770,000USD
    Depreciation And Amortization—2,918,000USD3,063,000USD3,227,000USD3,278,000USD3,333,000USD4,813,000USD4,607,000USD
    Reconciled Depreciation—2,918,000USD3,063,000USD3,227,000USD3,278,000USD3,333,000USD4,813,000USD4,607,000USD
    Unclassified Operating Expenses——————14,737,000USD—
    Income Tax Expense——————-4,777,724USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue6,646,000USD13,631,000USD63,533,000USD96,300,000USD55,846,000USD31,434,000USD10,680,000USD4,740,000USD
    Cost Of Revenue12,901,000USD18,962,000USD157,187,000USD13,758,000USD5,850,000USD125,623,000USD87,770,000USD56,024,000USD
    Gross Profit-6,255,000USD13,631,000USD-93,654,000USD96,300,000USD49,996,000USD-94,189,000USD10,680,000USD-51,284,000USD
    Research Development107,829,000USD135,001,000USD172,596,000USD320,454,000USD215,519,000USD125,623,000USD87,770,000USD56,024,000USD
    Selling General Administrative46,521,000USD74,169,000USD81,448,000USD84,232,000USD57,321,000USD33,896,000USD23,637,000USD15,808,000USD
    Unclassified Operating Expenses-12,901,000USD14,737,000USD-157,187,000USD—-5,850,000USD-125,623,000USD——
    Total Operating Expenses141,449,000USD223,907,000USD96,857,000USD404,686,000USD266,990,000USD33,896,000USD111,407,000USD71,832,000USD
    Operating Income-147,704,000USD-210,276,000USD-190,511,000USD-308,386,000USD-216,994,000USD-128,085,000USD-100,727,000USD-67,092,000USD
    Interest Income11,052,000USD17,288,000USD15,652,000USD5,842,000USD1,309,000USD2,400,000USD4,330,000USD2,190,000USD
    Net Interest Income11,052,000USD17,288,000USD15,652,000USD5,842,000USD1,309,000USD2,400,000USD2,578,000USD494,000USD
    Income Before Tax-136,315,000USD-186,262,000USD-160,928,000USD-281,721,000USD-212,151,000USD-173,387,000USD-98,149,000USD-66,598,000USD
    Net Income-136,315,000USD-186,262,000USD-160,928,000USD-255,056,000USD-212,151,000USD-173,387,000USD-98,149,000USD-66,598,000USD
    Net Income From Continuing Ops-136,315,000USD-186,262,000USD-173,169,000USD-281,721,000USD-212,151,000USD-173,387,000USD-98,149,000USD-66,598,000USD
    Ebit-136,315,000USD-195,539,000USD-190,511,000USD-308,386,000USD-216,994,000USD-128,085,000USD-96,397,000USD-64,902,000USD
    Ebitda-127,020,000USD-176,577,000USD-172,229,000USD-294,628,000USD-211,144,000USD-124,998,000USD-94,204,000USD-63,698,000USD
    Depreciation And Amortization9,295,000USD18,962,000USD18,282,000USD13,758,000USD5,850,000USD3,087,000USD2,193,000USD1,204,000USD
    Reconciled Depreciation12,901,000USD18,962,000USD18,239,000USD13,758,000USD5,850,000USD3,087,000USD2,193,000USD1,204,000USD
    Total Other Income Expense Net11,389,000USD24,014,000USD29,583,000USD26,665,000USD4,843,000USD-45,302,000USD2,578,000USD494,000USD
    Income Tax Expense——18,114,105USD-26,665,000USD-5,850,000USD-3,087,000USD-441,000USD2,190,000USD
    Interest Expense———5,842,000USD4,541,000USD2,400,000USD1,752,000USD1,696,000USD
    Net Income Applicable To Common Shares———-281,721,000USD-212,151,000USD-173,387,000USD-98,149,000USD-66,598,000USD
    Non Operating Income Net Other————4,843,000USD-45,302,000USD2,578,000USD494,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets260,103,000USD284,916,000USD318,937,000USD343,671,000USD371,632,000USD398,670,000USD440,694,000USD494,970,000USD
    Cash And Equivalents32,429,000USD———————
    Cash And Short Term Investments153,770,000USD174,822,000USD203,657,000USD215,423,000USD222,830,000USD240,425,000USD279,068,000USD296,923,000USD
    Short Term Investments121,341,000USD135,252,000USD157,029,000USD174,801,000USD181,581,000USD195,505,000USD243,012,000USD259,014,000USD
    Long Term Investments0USD0USD1,472,000USD10,305,000USD26,097,000USD32,286,000USD27,657,000USD33,607,000USD
    Total Current Assets157,953,000USD179,526,000USD208,704,000USD221,251,000USD230,397,000USD248,217,000USD291,909,000USD310,294,000USD
    Other Current Assets3,480,000USD4,000,000USD4,131,000USD5,146,000USD6,172,000USD5,386,000USD9,302,000USD9,244,000USD
    Total Liabilities106,665,000USD———————
    Total Current Liabilities32,592,000USD30,689,000USD36,071,000USD28,111,000USD28,673,000USD28,159,000USD38,522,000USD37,422,000USD
    Other Current Liabilities14,904,000USD———————
    Total Stockholder Equity153,438,000USD179,707,000USD207,184,000USD234,066,000USD261,364,000USD288,409,000USD318,726,000USD362,326,000USD
    Total Equity Including Noncontrolling Interest153,438,000USD———————
    Deferred Revenue0USD———————
    Net Receivables703,000USD704,000USD916,000USD682,000USD1,395,000USD2,406,000USD3,539,000USD4,127,000USD
    Property Plant Equipment Net92,100,000USD95,340,000USD98,534,000USD101,888,000USD104,911,000USD107,940,000USD110,892,000USD140,833,000USD
    Accounts Payable3,258,000USD3,277,000USD2,656,000USD3,504,000USD4,040,000USD4,190,000USD9,365,000USD6,349,000USD
    Short Term Debt4,922,000USD4,740,000USD4,562,000USD4,751,000USD5,656,000USD6,544,000USD7,416,000USD6,893,000USD
    Common Stock117,000USD116,000USD115,000USD115,000USD115,000USD115,000USD114,000USD114,000USD
    Retained Earnings-1,595,681,000USD-1,565,522,000USD-1,534,309,000USD-1,501,935,000USD-1,469,685,000USD-1,435,615,000USD-1,397,994,000USD-1,345,841,000USD
    Accumulated Other Comprehensive Income-117,000USD-77,000USD116,000USD153,000USD62,000USD191,000USD268,000USD835,000USD
    Total Liab—105,209,000USD111,753,000USD109,605,000USD110,268,000USD110,261,000USD121,968,000USD132,644,000USD
    Other Current Liab—22,090,000USD28,472,000USD19,851,000USD18,977,000USD17,213,000USD21,348,000USD23,580,000USD
    Capital Stock—119,000USD118,000USD118,000USD118,000USD118,000USD117,000USD117,000USD
    Cash—39,570,000USD46,628,000USD40,622,000USD41,249,000USD44,920,000USD36,056,000USD37,909,000USD
    Current Deferred Revenue—582,000USD381,000USD5,000USD—212,000USD393,000USD600,000USD
    Net Debt—37,215,000USD31,221,000USD38,623,000USD40,082,000USD38,409,000USD49,209,000USD61,069,000USD
    Short Long Term Debt Total—76,785,000USD77,849,000USD79,245,000USD81,331,000USD83,329,000USD85,265,000USD98,978,000USD
    Property Plant Equipment Gross—95,340,000USD134,757,000USD101,888,000USD104,911,000USD107,940,000USD146,028,000USD140,833,000USD
    Common Stock Shares Outstanding—120,030,638shares118,789,974shares118,998,693shares118,528,046shares118,375,540shares117,794,424shares117,769,161shares
    Non Current Assets Total—105,390,000USD110,233,000USD122,420,000USD141,235,000USD150,453,000USD148,785,000USD184,676,000USD
    Non Current Liabilities Total—74,520,000USD75,682,000USD81,494,000USD81,595,000USD82,102,000USD83,446,000USD95,222,000USD
    Non Current Liabilities Other—2,112,000USD2,112,000USD6,590,000USD5,600,000USD5,070,000USD5,070,000USD1,940,000USD
    Non Currrent Assets Other—10,050,000USD10,227,000USD10,227,000USD10,227,000USD10,227,000USD10,236,000USD10,236,000USD
    Net Working Capital—148,837,000USD172,633,000USD193,140,000USD201,724,000USD220,058,000USD253,387,000USD272,872,000USD
    Unclassified Non Current Liabilities—72,408,000USD73,570,000USD74,904,000USD75,995,000USD77,032,000USD78,376,000USD93,282,000USD
    Unclassified Equity—1,745,071,000USD1,741,144,000USD1,735,615,000USD1,730,754,000USD1,723,600,000USD1,716,221,000USD1,707,101,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets318,937,000USD440,694,000USD506,217,000USD705,561,000USD921,455,000USD622,457,000USD302,274,000USD213,032,000USD
    Other Current Assets4,131,000USD9,302,000USD14,539,000USD27,367,000USD8,826,000USD5,892,000USD5,662,000USD3,689,000USD
    Total Liab111,753,000USD121,968,000USD137,800,000USD221,622,000USD242,617,000USD238,012,000USD57,518,000USD52,563,000USD
    Total Stockholder Equity207,184,000USD318,726,000USD368,417,000USD483,939,000USD678,838,000USD384,445,000USD244,756,000USD160,469,000USD
    Other Current Liab28,472,000USD21,348,000USD28,199,000USD57,932,000USD45,612,000USD54,782,000USD17,505,000USD13,032,000USD
    Common Stock115,000USD114,000USD99,000USD97,000USD96,000USD88,000USD76,000USD65,000USD
    Capital Stock118,000USD117,000USD102,000USD100,000USD99,000USD91,000USD79,000USD68,000USD
    Retained Earnings-1,534,309,000USD-1,397,994,000USD-1,211,732,000USD-1,050,804,000USD-769,083,000USD-556,932,000USD-383,545,000USD-285,396,000USD
    Cash46,628,000USD36,056,000USD41,870,000USD61,333,000USD133,583,000USD167,347,000USD99,814,000USD190,514,000USD
    Cash And Short Term Investments203,657,000USD279,068,000USD315,175,000USD436,227,000USD615,910,000USD482,916,000USD221,427,000USD201,007,000USD
    Total Current Assets208,704,000USD291,909,000USD331,540,000USD502,074,000USD633,412,000USD494,323,000USD227,089,000USD205,196,000USD
    Total Current Liabilities36,071,000USD38,522,000USD39,094,000USD114,051,000USD81,284,000USD85,564,000USD27,806,000USD27,263,000USD
    Current Deferred Revenue381,000USD393,000USD685,000USD42,226,000USD21,483,000USD21,144,000USD2,787,000USD7,588,000USD
    Net Debt31,221,000USD49,209,000USD61,666,000USD48,005,000USD-18,765,000USD-70,049,000USD-72,887,000USD-175,630,000USD
    Short Term Debt4,562,000USD7,416,000USD6,176,000USD5,628,000USD5,577,000USD3,355,000USD1,692,000USD2,438,000USD
    Short Long Term Debt Total77,849,000USD85,265,000USD103,536,000USD109,338,000USD114,818,000USD97,298,000USD26,927,000USD14,884,000USD
    Long Term Investments1,472,000USD27,657,000USD980,000USD4,942,000USD100,664,000USD0USD39,440,000USD—
    Short Term Investments157,029,000USD243,012,000USD273,305,000USD374,894,000USD482,327,000USD315,569,000USD121,613,000USD10,493,000USD
    Net Receivables916,000USD3,539,000USD1,826,000USD38,480,000USD8,676,000USD5,515,000USD1,338,000USD500,000USD
    Accounts Payable2,656,000USD9,365,000USD4,719,000USD8,265,000USD8,612,000USD6,283,000USD5,822,000USD4,205,000USD
    Property Plant Equipment Net98,534,000USD110,892,000USD158,511,000USD66,069,000USD162,249,000USD99,392,000USD22,752,000USD5,125,000USD
    Property Plant Equipment Gross134,757,000USD146,028,000USD206,137,000USD66,069,000USD70,720,000USD99,392,000USD34,171,000USD5,125,000USD
    Accumulated Other Comprehensive Income116,000USD268,000USD15,000USD-1,854,000USD-762,000USD70,000USD22,000USD-2,000USD
    Common Stock Shares Outstanding118,789,974shares113,685,177shares98,411,162shares96,826,058shares94,747,311shares82,385,319shares68,190,741shares56,195,650shares
    Non Current Assets Total110,233,000USD148,785,000USD174,677,000USD203,487,000USD288,043,000USD128,134,000USD75,185,000USD7,836,000USD
    Non Current Liabilities Total75,682,000USD83,446,000USD98,706,000USD107,571,000USD161,333,000USD152,448,000USD29,712,000USD25,300,000USD
    Non Current Liabilities Other2,112,000USD5,070,000USD——800,000USD800,000USD702,000USD549,000USD
    Non Currrent Assets Other10,227,000USD10,236,000USD15,186,000USD132,476,000USD25,130,000USD9,000USD12,993,000USD526,000USD
    Net Working Capital172,633,000USD253,387,000USD292,446,000USD388,023,000USD552,128,000USD408,759,000USD199,283,000USD177,933,000USD
    Unclassified Non Current Liabilities73,570,000USD78,376,000USD98,706,000USD96,514,000USD98,571,000USD79,637,000USD23,195,000USD-3,950,000USD
    Unclassified Equity1,741,144,000USD1,716,221,000USD1,579,933,000USD1,536,400,000USD1,448,488,000USD941,128,000USD628,124,000USD445,734,000USD
    Other Assets——1USD22,456,000USD25,130,000USD95,826,000USD1,574,000USD2,711,000USD
    Deferred Long Term Liab———7,196,000USD9,870,000USD13,506,000USD1,338,000USD3,401,000USD
    Other Liab———3,861,000USD52,092,000USD58,505,000USD4,477,000USD12,854,000USD
    Inventory———1USD—1USD—1USD
    Net Tangible Assets———483,936,000USD678,835,000USD536,890,000USD274,465,000USD169,370,000USD
    Unclassified Non Current Assets———-22,456,000USD-25,130,000USD-67,093,000USD-1,574,000USD—
    Short Long Term Debt———————2,438,000USD
    Long Term Debt———————12,446,000USD
    Unclassified Current Liabilities———————-2,438,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation5,698,000USD
    Change To Account Receivables213,000USD
    Change To Liabilities-4,518,000USD
    Change In Working Capital-3,652,000USD
    Operating Cash Flow-54,256,000USD
    Capital Expenditures-319,000USD
    Net Investments38,463,000USD
    Investing Cash Flow38,144,000USD
    Financing Cash Flow1,736,000USD
    Change In Cash-14,376,000USD
    End Cash Flow42,479,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Operating Cash Flow-23,400,000USD———————
    End Cash Flow42,479,000USD———————
    Net Income—-31,213,000USD-32,374,000USD-32,250,000USD-34,070,000USD-37,621,000USD-52,153,000USD-47,678,000USD
    Depreciation—2,146,000USD-3,793,000USD3,227,000USD3,278,000USD3,333,000USD4,813,000USD4,607,000USD
    Stock Based Compensation—3,929,000USD5,528,000USD4,861,000USD7,154,000USD7,381,000USD9,120,000USD11,765,000USD
    Other Non Cash Items—280,000USD-20,576,000USD-716,000USD-1,022,000USD-1,529,000USD12,330,000USD-1,241,000USD
    Change To Account Receivables—212,000USD-233,000USD713,000USD1,010,000USD1,134,000USD588,000USD-2,479,000USD
    Change In Working Capital—-5,964,000USD1,055,000USD504,000USD73,000USD-5,373,000USD-1,909,000USD3,128,000USD
    Total Cash From Operating Activities—-30,822,000USD-23,314,000USD-24,374,000USD-24,587,000USD-33,809,000USD-27,799,000USD-29,419,000USD
    Capital Expenditures—-239,000USD-1,192,000USD-2,203,000USD-1,362,000USD-1,196,000USD-98,000USD-495,000USD
    Free Cash Flow—-31,061,000USD-24,506,000USD-26,577,000USD-25,949,000USD-35,005,000USD-27,897,000USD-29,914,000USD
    Investments—23,826,000USD28,585,000USD21,272,000USD19,591,000USD42,673,000USD22,816,000USD25,461,000USD
    Total Cashflows From Investing Activities—23,587,000USD27,630,000USD21,272,000USD19,591,000USD42,673,000USD22,816,000USD25,461,000USD
    Change In Cash—-7,235,000USD6,006,000USD-627,000USD-3,671,000USD8,864,000USD-1,853,000USD992,000USD
    Begin Period Cash Flow—56,855,000USD50,849,000USD51,476,000USD55,147,000USD46,283,000USD48,136,000USD36,917,000USD
    End Period Cash Flow—49,620,000USD56,855,000USD50,849,000USD51,476,000USD55,147,000USD46,283,000USD37,909,000USD
    Total Cash From Financing Activities——1,690,000USD2,475,000USD1,325,000USD0USD3,130,000USD0USD
    Issuance Of Capital Stock——0USD0USD0USD0USD0USD0USD
    Other Cashflows From Investing Activities——359,000USD3,000USD122,000USD———
    Other Cashflows From Financing Activities——1,690,000USD2,475,000USD1,325,000USD—3,130,000USD-961,000USD
    Unclassified Operating Cash Flow——26,846,000USD—————
    Unclassified Investing Cash Flow———2,200,000USD1,240,000USD1,196,000USD——
    Sale Purchase Of Stock——————-666,000USD666,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-136,315,000USD-186,262,000USD-160,928,000USD-281,721,000USD-212,151,000USD-173,387,000USD-98,149,000USD-66,598,000USD
    Depreciation9,295,000USD18,962,000USD18,282,000USD13,758,000USD5,850,000USD3,087,000USD2,193,000USD1,204,000USD
    Stock Based Compensation24,924,000USD41,496,000USD43,459,000USD78,733,000USD54,364,000USD30,753,000USD17,410,000USD6,293,000USD
    Other Non Cash Items-247,000USD4,888,000USD-52,258,000USD-24,268,000USD-13,031,000USD113,091,000USD-7,791,000USD19,042,000USD
    Change To Account Receivables2,624,000USD-1,113,000USD36,654,000USD-29,804,000USD-3,160,000USD-5,515,000USD500,000USD-500,000USD
    Change In Working Capital-3,741,000USD-1,958,000USD19,182,000USD-34,710,000USD2,098,000USD-12,773,000USD3,640,000USD1,744,000USD
    Total Cash From Operating Activities-106,084,000USD-122,874,000USD-132,263,000USD-248,208,000USD-162,870,000USD-39,229,000USD-83,175,000USD-38,650,000USD
    Capital Expenditures-5,953,000USD-730,000USD-6,153,000USD-35,566,000USD-50,704,000USD-4,932,000USD-7,395,000USD-2,303,000USD
    Free Cash Flow-112,037,000USD-123,604,000USD-138,416,000USD-283,774,000USD-213,574,000USD-44,161,000USD-90,570,000USD-40,953,000USD
    Investments116,757,000USD12,218,000USD120,424,000USD166,751,000USD-273,319,000USD-156,144,000USD-150,058,000USD1,840,000USD
    Total Cashflows From Investing Activities111,166,000USD12,218,000USD112,665,000USD166,751,000USD-324,023,000USD-161,076,000USD-157,453,000USD-463,000USD
    Total Cash From Financing Activities5,490,000USD99,892,000USD85,000USD9,207,000USD453,129,000USD282,838,000USD149,928,000USD140,780,000USD
    Issuance Of Capital Stock0USD74,531,000USD0USD-31,000USD411,735,000USD272,693,000USD162,406,000USD134,577,000USD
    Change In Cash10,572,000USD-5,814,000USD-19,463,000USD-72,250,000USD-33,764,000USD67,533,000USD-90,700,000USD101,667,000USD
    Begin Period Cash Flow46,283,000USD41,870,000USD61,333,000USD133,583,000USD182,574,000USD99,814,000USD190,741,000USD89,074,000USD
    End Period Cash Flow56,855,000USD36,056,000USD41,870,000USD61,333,000USD148,810,000USD167,347,000USD100,041,000USD190,741,000USD
    Other Cashflows From Investing Activities362,000USD——202,317,000USD-273,319,000USD-156,144,000USD-150,058,000USD1,840,000USD
    Other Cashflows From Financing Activities5,490,000USD5,070,000USD85,000USD9,207,000USD41,394,000USD490,000USD2,522,000USD6,203,000USD
    Unclassified Financing Cash Flow—20,291,000USD——-20,714,000USD33,934,000USD162,406,000USD146,884,000USD
    Unclassified Investing Cash Flow——-1,606,000USD-166,751,000USD273,319,000USD156,144,000USD150,058,000USD-1,840,000USD
    Change To Liabilities———14,252,000USD5,907,000USD-1,554,000USD4,277,000USD4,254,000USD
    Change To Inventory————-5,907,000USD1,554,000USD-4,277,000USD-4,254,000USD
    Net Borrowings————0USD—-15,000,000USD-15,000,000USD
    Sale Purchase Of Stock————432,449,000USD248,414,000USD2,522,000USD2,693,000USD
    Cash And Cash Equivalents Changes————-33,764,000USD82,533,000USD-90,700,000USD101,667,000USD
    Dividends Paid——————-2,522,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2024Quarterly · 2024-06-30ProductClinical Development Milestone5,000,000USD0000950170-24-096187
    Q2 2024Quarterly · 2024-06-30ProductResearch Services1,800,000USD0000950170-24-096187
    FY 2023Yearly · 2023-12-31ProductCommercial Option Exercise10,000,000USD0000950170-25-033510
    FY 2023Yearly · 2023-12-31ProductOther11,100,000USD0000950170-25-033510
    FY 2023Yearly · 2023-12-31ProductUpfront Fee And Equity Premium31,200,000USD0000950170-25-033510
    Q1 2023Quarterly · 2023-03-31ProductCommercial Option Exercise10,000,000USD0000950170-24-056869
    Q1 2023Quarterly · 2023-03-31ProductOther11,100,000USD0000950170-24-056869
    Q1 2023Quarterly · 2023-03-31ProductUpfront Fee And Equity Premium31,200,000USD0000950170-24-056869
    FY 2022Yearly · 2022-12-31ProductAssociated With Collaboration Services1,300,000USD0000950170-24-020158
    FY 2022Yearly · 2022-12-31ProductCommercial Option Exercise13,000,000USD0000950170-24-020158
    FY 2022Yearly · 2022-12-31ProductOther800,000USD0000950170-24-020158
    FY 2022Yearly · 2022-12-31ProductResearch Services2,500,000USD0000950170-24-020158
    FY 2022Yearly · 2022-12-31ProductUpfront Fee1,600,000USD0000950170-24-020158
    FY 2022Yearly · 2022-12-31ProductUpfront Fee And Equity Premium23,100,000USD0000950170-24-020158
    Q1 2022Quarterly · 2022-03-31ProductOther1,100,000USD0000950170-22-007389
    Q1 2022Quarterly · 2022-03-31ProductResearch Services1,300,000USD0000950170-22-007389
    Q1 2022Quarterly · 2022-03-31ProductUpfront Fee1,300,000USD0000950170-22-007389
    Q1 2022Quarterly · 2022-03-31ProductUpfront Fee And Equity Premium6,100,000USD0000950170-22-007389
    FY 2021Yearly · 2021-12-31ProductOther3,200,000USD0000950170-23-005067
    FY 2021Yearly · 2021-12-31ProductResearch Services6,000,000USD0000950170-23-005067
    FY 2021Yearly · 2021-12-31ProductUpfront Fee6,100,000USD0000950170-23-005067
    FY 2021Yearly · 2021-12-31ProductUpfront Fee And Equity Premium14,200,000USD0000950170-23-005067
    Q3 2021Quarterly · 2021-09-30ProductResearch Services1,500,000USD0000950170-22-021840
    Q3 2021Quarterly · 2021-09-30ProductUpfront Fee1,500,000USD0000950170-22-021840
    Q3 2021Quarterly · 2021-09-30ProductUpfront Fee And Equity Premium4,100,000USD0000950170-22-021840
    Q2 2021Quarterly · 2021-06-30ProductOther800,000USD0000950170-22-014236
    Q2 2021Quarterly · 2021-06-30ProductResearch Services1,300,000USD0000950170-22-014236
    Q2 2021Quarterly · 2021-06-30ProductUpfront Fee1,200,000USD0000950170-22-014236
    Q2 2021Quarterly · 2021-06-30ProductUpfront Fee And Equity Premium3,800,000USD0000950170-22-014236
    Q1 2021Quarterly · 2021-03-31ProductOther1,300,000USD0000950170-22-007389
    Q1 2021Quarterly · 2021-03-31ProductResearch Services2,500,000USD0000950170-22-007389
    Q1 2021Quarterly · 2021-03-31ProductUpfront Fee1,200,000USD0000950170-22-007389
    Q1 2021Quarterly · 2021-03-31ProductUpfront Fee And Equity Premium1,800,000USD0000950170-22-007389
    Q3 2020Quarterly · 2020-09-30ProductOther500,000USD0000950170-21-003066
    Q3 2020Quarterly · 2020-09-30ProductResearch Services1,300,000USD0000950170-21-003066
    Q3 2020Quarterly · 2020-09-30ProductUpfront Fee600,000USD0000950170-21-003066
    Q3 2020Quarterly · 2020-09-30ProductUpfront Fee And Equity Premium3,200,000USD0000950170-21-003066
    Q1 2020Quarterly · 2020-03-31ProductResearch Services1,700,000USD0001564590-21-024037
    Q1 2020Quarterly · 2020-03-31ProductUpfront Fee800,000USD0001564590-21-024037
    FY 2019Yearly · 2019-12-31ProductResearch Services6,900,000USD0000950170-22-002293
    FY 2019Yearly · 2019-12-31ProductUpfront Fee3,100,000USD0000950170-22-002293
    FY 2019Yearly · 2019-12-31ProductUpfront Fee And Equity Premium700,000USD0000950170-22-002293
    FY 2018Yearly · 2018-12-31ProductOther40,000USD0001564590-21-008086
    FY 2018Yearly · 2018-12-31ProductResearch Services2,400,000USD0001564590-21-008086
    FY 2018Yearly · 2018-12-31ProductUpfront Fee200,000USD0001564590-21-008086
    FY 2018Yearly · 2018-12-31ProductUpfront Fee And Equity Premium2,100,000USD0001564590-21-008086
    FY 2017Yearly · 2017-12-31ProductResearch Services2,000,000USD0001564590-20-008141
    FY 2017Yearly · 2017-12-31ProductUpfront Fee And Equity Premium2,100,000USD0001564590-20-008141
    FY 2016Yearly · 2016-12-31ProductResearch Services2,300,000USD0001564590-19-006258
    FY 2016Yearly · 2016-12-31ProductUpfront Fee And Equity Premium2,100,000USD0001564590-19-006258

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.